These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 21285128

  • 1. Early short-term imatinib treatment is sufficient to prevent the development of chronic allograft nephropathy.
    Savikko J, Rintala JM, Rintala SE, Koskinen PK, von Willebrand E.
    Nephrol Dial Transplant; 2011 Sep; 26(9):3026-32. PubMed ID: 21285128
    [Abstract] [Full Text] [Related]

  • 2. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy.
    Savikko J, Taskinen E, Von Willebrand E.
    Transplantation; 2003 Apr 27; 75(8):1147-53. PubMed ID: 12717194
    [Abstract] [Full Text] [Related]

  • 3. Early short-term platelet-derived growth factor inhibition prevents the development of chronic allograft nephropathy in experimental rat kidney transplantation.
    Savikko J, Rintala J, von Willebrand E.
    Transplant Proc; 2006 Dec 27; 38(10):3231-2. PubMed ID: 17175231
    [Abstract] [Full Text] [Related]

  • 4. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM, Savikko J, Rintala SE, von Willebrand E.
    Nephrol Dial Transplant; 2008 Nov 27; 23(11):3446-55. PubMed ID: 18558624
    [Abstract] [Full Text] [Related]

  • 5. Sirolimus attenuates chronic allograft nephropathy in an experimental rat kidney transplantation model.
    Savikko J, von Willebrand E.
    Transplant Proc; 2006 Oct 27; 38(8):2699-700. PubMed ID: 17098043
    [Abstract] [Full Text] [Related]

  • 6. The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta.
    Rintala JM, Savikko J, Rintala SE, von Willebrand E.
    Transplant Proc; 2006 Oct 27; 38(8):2719-21. PubMed ID: 17098049
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection.
    Rintala SE, Savikko J, Rintala JM, von Willebrand E.
    Transplant Proc; 2006 Dec 27; 38(10):3236-8. PubMed ID: 17175233
    [Abstract] [Full Text] [Related]

  • 8. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM, Savikko J, Rintala SE, von Willebrand E.
    Transplant Proc; 2006 Dec 27; 38(10):3239-40. PubMed ID: 17175234
    [Abstract] [Full Text] [Related]

  • 9. The effect of acute rejection and cyclosporin A-treatment on induction of platelet-derived growth factor and its receptors during the development of chronic rat renal allograft rejection.
    Savikko J, Kallio EA, Taskinen E, von Willebrand E.
    Transplantation; 2002 Feb 27; 73(4):506-11. PubMed ID: 11889420
    [Abstract] [Full Text] [Related]

  • 10. Early induction of platelet-derived growth factor ligands and receptors in acute rat renal allograft rejection.
    Savikko J, Kallio EA, von Willebrand E.
    Transplantation; 2001 Jul 15; 72(1):31-7. PubMed ID: 11468531
    [Abstract] [Full Text] [Related]

  • 11. Different effects of tacrolimus and cyclosporine on PDGF induction and chronic allograft injury: evidence for improved kidney graft outcome.
    Savikko J, Teppo AM, Taskinen E, von Willebrand E.
    Transpl Immunol; 2014 Sep 15; 31(3):145-51. PubMed ID: 25158212
    [Abstract] [Full Text] [Related]

  • 12. Oral Platelet-Derived Growth Factor and Vascular Endothelial Growth Factor Inhibitor Sunitinib Prevents Chronic Allograft Injury in Experimental Kidney Transplantation Model.
    Rintala JM, Savikko J, Palin N, Rintala SE, Koskinen PK, von Willebrand E.
    Transplantation; 2016 Jan 15; 100(1):103-10. PubMed ID: 26262503
    [Abstract] [Full Text] [Related]

  • 13. The effect of platelet-derived growth factor ligands in rat cardiac allograft vasculopathy and fibrosis.
    Tuuminen R, Nykänen A, Keränen MA, Krebs R, Alitalo K, Koskinen PK, Lemström KB.
    Transplant Proc; 2006 Dec 15; 38(10):3271-3. PubMed ID: 17175246
    [Abstract] [Full Text] [Related]

  • 14. Role of platelet-derived growth factor and vascular endothelial growth factor in obliterative airway disease.
    Tikkanen JM, Hollmén M, Nykänen AI, Wood J, Koskinen PK, Lemström KB.
    Am J Respir Crit Care Med; 2006 Nov 15; 174(10):1145-52. PubMed ID: 16917119
    [Abstract] [Full Text] [Related]

  • 15. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.
    Basciani S, Brama M, Mariani S, De Luca G, Arizzi M, Vesci L, Pisano C, Dolci S, Spera G, Gnessi L.
    Cancer Res; 2005 Mar 01; 65(5):1897-903. PubMed ID: 15753388
    [Abstract] [Full Text] [Related]

  • 16. Chronic rejection of rat renal allograft. I. Histological differentiation between chronic rejection and cyclosporin nephrotoxicity.
    Yilmaz S, Taskinen E, Paavonen T, Mennander A, Häyry P.
    Transpl Int; 1992 May 01; 5(2):85-95. PubMed ID: 1627245
    [Abstract] [Full Text] [Related]

  • 17. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
    Zhang W, Liu M, Wu Y, Zhu P, Yin C, Zhang W, Gu M.
    J Surg Res; 2007 Dec 01; 143(2):428-36. PubMed ID: 17628598
    [Abstract] [Full Text] [Related]

  • 18. Sirolimus inhibits lymphangiogenesis in rat renal allografts, a novel mechanism to prevent chronic kidney allograft injury.
    Palin NK, Savikko J, Koskinen PK.
    Transpl Int; 2013 Feb 01; 26(2):195-205. PubMed ID: 23167600
    [Abstract] [Full Text] [Related]

  • 19. Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation.
    Nykänen AI, Krebs R, Tikkanen JM, Raisky O, Sihvola R, Wood J, Koskinen PK, Lemström KB.
    Transplantation; 2005 Jan 27; 79(2):182-9. PubMed ID: 15665766
    [Abstract] [Full Text] [Related]

  • 20. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications.
    Khanna AK, Plummer MS, Hilton G, Pieper GM, Ledbetter S.
    Circulation; 2004 Dec 21; 110(25):3822-9. PubMed ID: 15583082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.